Drug
PF 07054894
PF 07054894: highest development phase Phase 1, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| PF-07054894 NCT05549323 | Phase 1 | Ulcerative Colitis |
Latest
No recent events.
Follow PF 07054894 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.